Surgical treatment of multidrug-resistant tuberculosis (MDR TB)

S. A. Cherenko, B. V. Radionov, E. R. Tarasenko (Kiev, Ukraine)

Source: Annual Congress 2003 - Resistance in adults and children
Session: Resistance in adults and children
Session type: Thematic Poster Session
Number: 3264
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. A. Cherenko, B. V. Radionov, E. R. Tarasenko (Kiev, Ukraine). Surgical treatment of multidrug-resistant tuberculosis (MDR TB). Eur Respir J 2003; 22: Suppl. 45, 3264

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Surgical treatment of multidrug resistant pulmonary tuberculosis (MDR-TB)
Source: Annual Congress 2009 - Treatment of tuberculosis at times of emerging drug resistance
Year: 2009


Surgical treatment of destructive pulmonary tuberculosis (TB) with multi-drug resistance (MDR)
Source: Eur Respir J 2004; 24: Suppl. 48, 723s
Year: 2004

Treatment of TB
Source: Eur Respir Mon 2012; 58: 154-166
Year: 2012


Management and treatment of multidrug-resistant tuberculosis
Source: International Congress 2019 – Tuberculosis: latest advances and challenges in patient management
Year: 2019


Management of multidrug-resistant tuberculosis and patients in retreatment
Source: Eur Respir J 2005; 25: 928-936
Year: 2005



Effectiveness of the WHO regimen for treatment of multidrug resistant tuberculosis (MDR-TB)
Source: Annual Congress 2013 –Drug-resistant tuberculosis: new clinical and public health insights
Year: 2013

Multidrug resistant tuberculosis (MDR – TB) treatment outcomes in Iran
Source: Eur Respir J 2004; 24: Suppl. 48, 657s
Year: 2004

Long-term treatment outcomes in multidrug-resistant tuberculosis (MDR-TB)
Source: Annual Congress 2007 - Drug-resistant and multidrug-resistant tuberculosis
Year: 2007


Multidrug-resistant tuberculosis (MDR-TB)
Source: Breathe 2010; 6: 283
Year: 2010

Multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis: epidemiology, diagnosis and treatment
Source: Annual Congress 2008 - Infection year in review
Year: 2008


Treatment results of multidrug resistant pulmonary tuberculosis (MDR-TB)
Source: Eur Respir J 2005; 26: Suppl. 49, 199s
Year: 2005

Artificial pneumothorax in the treatment of multi drug resistant tuberculosis (MDR TB)
Source: Eur Respir J 2006; 28: Suppl. 50, 586s
Year: 2006

Our experience in multi drug resistant tuberculosis (MDR TB) treatment
Source: Eur Respir J 2005; 26: Suppl. 49, 652s
Year: 2005

Efficacy and safety of linezolid for the treatment of multidrug resistant tuberculosis (MDR-TB) and disease by non tuberculous mycobacteria (NTM)
Source: Annual Congress 2011 - Treatment of tuberculosis and adverse drug reactions
Year: 2011

Recurrence after successful treatment of pulmonary tuberculosis (TB) with multidrug-resistance (MDR)
Source: Annual Congress 2008 - The challenge of multidrug-resistant tuberculosis
Year: 2008


Management of MDR tuberculosis
Source: Short video discussion 2021
Year: 2021

Analysis of multidrug-resistant tuberculosis
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1
Year: 2014


Linezolid in the treatment of patients with MDR TB and XDR TB
Source: Annual Congress 2013 –Drug-resistant tuberculosis
Year: 2013


Comorbidome in multidrug-resistant tuberculosis patients
Source: Virtual Congress 2020 – Tuberculosis and comorbidities
Year: 2020


Treatment possibilities of multi-drug resistant (MDR) tuberculosis
Source: Eur Respir J 2003; 22: Suppl. 45, 525s
Year: 2003